Alphagan Ruling Would Limit Need For Patent Certifications

ANDA applicants are not required to certify to patents other than those covering the compound or the method of use being pursued, a Los Angeles federal court ruling in Allergan's Alphagan patent litigation against Alcon states

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet